Cogent Biosciences
COGT
#5783
Rank
A$1.38 B
Marketcap
$12.53
Share price
0.51%
Change (1 day)
48.44%
Change (1 year)

Earnings for Cogent Biosciences (COGT)

Earnings in 2024 (TTM): -A$0.39 Billion

According to Cogent Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.34 Billion a decrease over its 2022 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cogent Biosciences from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.39 Billion16.19%
2023 -A$0.34 Billion40.78%
2022 -A$0.24 Billion95.68%
2021 -A$0.13 Billion114.09%
2020 -A$56.4 Million9.67%
2019 -A$51.43 Million-10.63%
2018 -A$57.54 Million37.68%
2017 -A$41.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$29.02 Million-93.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion-54.75%๐Ÿ‡บ๐Ÿ‡ธ USA